HAQ continuous | HAQ dichotomous | |||
---|---|---|---|---|
Reader 1 | Reader 2 | Reader 1 | Reader 2 | |
β (95% CI) | β (95% CI) | OR (95% CI) | OR (95% CI) | |
Predictors, separate models† | ||||
Erosions all joint groups | 0.002 (0.001 to 0.003)** | 0.002 (0.001 to 0.003)*** | 1.008 (1.003 to 1.014)** | 1.007 (1.003 to 1.012)** |
Real JSN all joint groups | 0.002 (0.001 to 0.003)*** | 0.003 (0.002 to 0.004)*** | 1.010 (1.004 to 1.016)*** | 1.011 (1.006 to 1.016)*** |
SLUX all joint groups | 0.002 (−0.009 to 0.013) | 0.017 (0.003 to 0.031)* | 1.055 (0.994 to 1.119) | 1.079 (1.012 to 1.051)* |
Predictors, combined models‡ | ||||
Erosions all joint groups | – | – | – | – |
Real JSN all joint groups | 0.003 (0.002 to 0.005)*** | 0.003 (0.002 to 0.004)*** | 1.010 (1.004 to 1.016)*** | 1.011 (1.006 to 1.016)*** |
SLUX all joint groups | −0.017 (−0.030 to −0.004)* | – | – | – |
*p≤0.05; **p≤0.01; ***p≤0.001; otherwise NS.
†GEE, adjusted for age, gender, baseline DAS28, treatment group.
‡GEE (backward selection), adjusted for age, gender, baseline DAS28, treatment group; all results are last step of the regression.
–, variable not included in the final model; DAS28, Disease Activity Score 28; GEE, generalised estimating equations; HAQ, Health Assessment Questionnaire; JSN, joint space narrowing; NS, not significant; SLUX, (sub)luxation.